ABNX — Abionyx Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00- €127.05m
- €127.34m
- €4.06m
Annual cashflow statement for Abionyx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.82 | -4.21 | -3.52 | -4.38 | -5.55 |
| Depreciation | |||||
| Non-Cash Items | 0.755 | 0.615 | -0.871 | 0.64 | 0.89 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.74 | 0.097 | 0.538 | -0.028 | 1.6 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.69 | -3.36 | -3.7 | -3.63 | -2.93 |
| Capital Expenditures | -0.166 | -0.175 | -0.13 | -0.076 | -0.242 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.5 | — | — | — | 0.037 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 1.34 | -0.175 | -0.13 | -0.076 | -0.205 |
| Financing Cash Flow Items | — | — | — | — | 2.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.97 | -0.194 | 3.89 | 2.84 | 3.42 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.38 | -3.73 | 0.058 | -0.866 | 0.287 |